Envestnet Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $732K | Buy |
|
|||||
|
2023
Q1 | $380K | Sell |
|
|||||
|
2022
Q4 | $344K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $264K | Sell |
|
|||||
|
2021
Q2 | $373K | Sell |
|
|||||
|
2021
Q1 | $272K | Buy |
|
|||||
|
2020
Q4 | $290K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $270K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $345K | Buy |
|